Colucid Pharma Cmn (CLCD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLCD | ABUS | ANNX | ||
| Company | Colucid Pharma Cmn | Arbutus Biopharma Corp | Annexon Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 46.50 | 4.59 | 5.39 | ||
| High | 46.55 | 4.66 | 5.51 | ||
| Low | 46.45 | 4.55 | 5.26 | ||
| Last | 46.53 | 4.59 | 5.39 | ||
| Change | +0.03 | -0.04 | -0.02 | ||
| Percent Change | +0.06% | -0.86% | -0.37% | ||
| Volume | 127,000 | 969,200 | 1,960,100 | ||
| 20-Day Average Volume | 245,780 | 1,413,520 | 3,213,125 | ||
| Previous | 46.50 | 4.63 | 5.41 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 46.44 | 4.48 | 5.41 | ||
| 20-Day Raw Stochastic | 70.00% | 57.63% | 34.62% | ||
| 20-Day Relative Strength | 67.22 | 51.83 | 49.75 | ||
| Weighted Alpha | +162.70 | +28.03 | +51.96 | ||
| Today's Opinion | N/A | 64% Buy | Hold | ||
| Yesterday's Opinion | N/A | 64% Buy | Hold | ||
| Last Month's Opinion | N/A | 100% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.06% since 02/21/17 | +5.28% since 08/03/26 | +2.67% since 08/03/26 | ||
| Low | 46.45 on 02/28/17 | 4.38 on 08/04/26 | 5.26 on 08/04/26 | ||
| High | 46.55 on 02/28/17 | 4.69 on 08/05/26 | 5.70 on 08/07/26 | ||
| 1-Month | |||||
| %Chg | +0.61% since 01/27/17 | -4.38% since 07/10/26 | -7.07% since 07/10/26 | ||
| Low | 46.20 on 01/30/17 | 4.25 on 07/23/26 | 4.76 on 07/29/26 | ||
| High | 46.65 on 02/08/17 | 4.85 on 07/13/26 | 6.58 on 07/16/26 | ||
| 3-Month | |||||
| %Chg | +37.26% since 11/28/16 | +5.76% since 05/08/26 | -5.27% since 05/08/26 | ||
| Low | 31.25 on 01/06/17 | 4.06 on 06/11/26 | 4.46 on 06/16/26 | ||
| High | 46.65 on 02/08/17 | 5.38 on 07/09/26 | 6.58 on 07/16/26 | ||
| 6-Month | |||||
| %Chg | +441.05% since 08/26/16 | +10.34% since 02/10/26 | -3.92% since 02/10/26 | ||
| Low | 8.65 on 08/29/16 | 3.85 on 02/12/26 | 4.46 on 06/16/26 | ||
| High | 46.65 on 02/08/17 | 5.38 on 07/09/26 | 6.61 on 04/17/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 897,098 | 914,601 | 886,391 | ||
| Shares Outstanding, K | 19,280 | 197,538 | 163,843 | ||
| Annual Sales, $M | 0 | 14,080,000 | 0 | ||
| Annual Net Income, $M | -30,740,000 | -33,500,000 | -206,690,000 | ||
| Last Qtr Sales, $M | N/A | 179,130,000 | 0 | ||
| Last Qtr Income, $M | N/A | 169,700,000 | -44,140,000 | ||
| 60-Month Beta | 1.51 | 0.64 | 1.18 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 0.87 on 05/13/26 | -0.23 on 05/07/26 | ||
| Latest Earnings Date | 03/01/17 | 08/12/26 | 08/13/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 5.47 | 0.00 | ||